Bogdan Ivanišević, partner and co-head of BDK’s Life Sciences and Healthcare sector group, and Slobodan Trivić, associate in the same group, authored the Serbia chapter of the 2016 edition of The Life Sciences Law Review. The chapter provides a comprehensive overview of Serbian regulatory framework covering pharmaceutical, biotechnology and medical device industries. Download the Serbia chapter.
If you would like to obtain the entire publication, click here.